Floatz logo

BETAMETHASONE IMPURITY B

Oral Ulcer Due to Pemphius Vularis

Beni-Suef UniversitySmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Oral Ulcer Due to Pemphius Vularis cohort.

Asset / SponsorPhaseRating
Humax-Cd20
Novartis Pharmaceuticals
Phase 3B
JNJ-78436735
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
MODERNA COVID-19 VACCINE RNA
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
Monovalent [B.1.351] Cov2 Pres Dtm-As03
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
METHOTREXATE
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
Tozinameran
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
bnt162b2
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CC

Same molecule, other indications

BETAMETHASONE IMPURITY B is also rated in:

PsoriasisDormant
B
Indicative ·
62 / 100
View asset →
colon adenocarcinomaDormant
B
Indicative ·
57 / 100
View asset →
colorectal carcinomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →